[{"id":"920d2ff6-65ca-4a1f-8796-82fb96b5cdac","acronym":"","url":"https://clinicaltrials.gov/study/NCT00005780","created_at":"2021-01-17T23:51:08.073Z","updated_at":"2024-07-02T16:35:56.765Z","phase":"Phase 2","brief_title":"Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma","source_id_and_acronym":"NCT00005780","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • prednisone • BiovaxID (dasiprotimut-T) • Leukine (sargramostim)"],"overall_status":"Completed","enrollment":" Enrollment 26","initiation":"Initiation: 06/01/2000","start_date":" 06/01/2000","primary_txt":" Primary completion: 06/09/2021","primary_completion_date":" 06/09/2021","study_txt":" Completion: 06/16/2021","study_completion_date":" 06/16/2021","last_update_posted":"2023-01-31"}]